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omputed
omography Coronary
ngiography as an Anatomic
asis for Risk Stratification
éjà Vu or Something New?*
ohn J. Mahmarian, MD, FACC
ew York, New York; and Houston, Texas
ore than 2 decades ago, the initial clinical trials were
ublished (1,2) addressing whether the extent of obstructive
oronary artery disease (CAD) by invasive coronary angiog-
aphy could predict subsequent patient outcome and in
hom coronary revascularization would be most beneficial.
ince that time, noninvasive techniques such as stress
chocardiography and myocardial perfusion imaging (MPI)
ave largely supplanted an initial angiographic assessment
n most patients. The basis for this fundamental shift from
natomy to physiology stems from a large foundation of
linical data demonstrating that inducible ischemia, in
onjunction with left ventricular function, is a better barom-
ter of risk compared to an anatomic measure (3,4) and one
hat can more accurately direct therapeutic decisions and
hereby affect patient care.
See page 1161
Recently, there has been renewed interest in revisiting
maging of the coronary anatomy, but this time noninva-
ively using computed tomography. Computed tomography
ngiography (CTA) has developed at an extraordinary
echnical pace, with current scanners providing rapid patient
hroughput within a short 10- to 15-s breath hold. Im-
rovements in temporal and spatial resolution, accompanied
y sophisticated software packages for processing extensive
mage files, have resulted in breathtaking 3-dimensional
epictions of the heart and coronary arteries. Studies di-
ectly comparing CTA to traditional angiography have
ielded favorable results, barring exceptions due to image
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Weill Medical College of Cornell University, New York, New York; andw
he Nuclear Cardiology and CT Laboratories, Methodist DeBakey Heart Center,
epartment of Cardiology, The Methodist Hospital, Houston, Texas.istortion from motion artifacts and/or extensive calcifica-
ion, which limits visualization of the arterial lumen (5).
lthough stenosis severity is generally overestimated by
TA (or underestimated by invasive angiography, depend-
ng on your vantage point), the negative predictive accuracy
f CTA for excluding significant CAD is reported to be
98% (5).
Despite these advances, CTA is still looking for its
niche” in clinical practice. This is not unexpected, as every
maging technique generally undergoes multiple iterations
f validation before ultimately defining its role in clinical
ecision-making.
he Present Study
he study by Min et al. (6) in this issue of the Journal is one
f 2 recent papers addressing the prognostic value of
ultidetector CTA (6,7). This is a large registry study that
ncluded a potpourri of patients, ranging from those who
ere asymptomatic (38%) to those having typical anginal
ymptoms (2%). The pretest likelihood of CAD was based
n standard criteria, with most (50%) falling into the
ntermediate range. Computed tomography angiography
as performed using a 16-slice system with images visually
ssessed to estimate coronary atherosclerotic plaque severity.
ultiple phases were used to identify images exhibiting the
east cardiac motion. The coronary artery tree was scored on
he basis of a modified American Heart Association classi-
cation, with unevaluable segments scored similarly to the
ost proximal interpretable segment. The Duke prognostic
AD index was also applied to the angiographic results (8).
he primary end point was all-cause mortality based on the
ocial Security Death Index.
The salient results from this trial are that a normal CTA
redicts a very low mortality rate of only 0.3% at 15.3
onths of follow-up as compared with the overall mortality
f 3.5%. The presence, extent, and severity of CAD were
ndependent predictors of all-cause mortality, as was the
resence of left main stenosis. The Duke Prognostic Index
as also a significant predictor of subsequent mortality.
The findings from this study are not dissimilar from those
reviously reported, with invasive coronary angiography
ith the worst outcome in patients who had triple-vessel
nd/or left main stenosis (1,2). Because CTA correlates
easonably well with stenosis severity by invasive angiogra-
hy, these findings are not unexpected (5).
This study has several important limitations. Because it is
single-center retrospective registry, the results may not be
pplicable to general clinical practice. Also, although the
uthors have shown a relationship between CTA results and
ll-cause mortality, it remains to be seen whether CTA is as
redictive of cardiac death and nonfatal myocardial infarc-
ion. Finally, little is known of treatment in these patients,
here 30% had moderate to severe triple-vessel CAD by
TA and 10% had significant left main stenosis. Treatment
as left to the discretion of practicing physicians, and it is
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Editorial Comment September 18, 2007:1171–3nticipated that many patients underwent coronary revas-
ularization. All-cause mortality may not be reflective of
ardiac events in high-risk groups who are successfully
evascularized. Conversely, of the 39 patients who died,
nformation regarding procedurally related deaths is avail-
ble on only 10. Such information is critical to the proper
nterpretation of the study results.
he Challenges Ahead
espite these limitations, the authors are to be commended
or an important initial step in assessing risk with this
elatively new imaging modality. There are, however, many
uestions that remain unanswered. First and foremost, how
ill CTA integrate with other, more formally studied
echniques used in risk stratification? For example, it is well
nown that a coronary artery calcium score (CACS) of 0,
ven in symptomatic patients, will rarely (1%) be associ-
ted with significant CAD (9). In support of this, a CACS
f 0 also predicts an exceedingly low (0.4%) annual risk for
ny subsequent cardiac event, let alone death, and is much
impler to perform than CTA, with less radiation exposure
nd no need for iodinated contrast (10,11). It is unfortunate
hat the authors did not perform a CACS as part of their
TA procedure. This would have provided a unique op-
ortunity to compare both techniques in the same patients.
Stress MPI is currently the most widely utilized tech-
ique for assessing risk, with several decades of clinical trials
panning the entire spectrum of CAD (12,13). Patients at
ntermediate clinical risk have a reported annualized 0.6%
eath and reinfarction rate with a normal perfusion study,
ersus a 6% event rate when the scan is moderately to
everely abnormal (12). Stress MPI has consistently been
hown superior to coronary angiographic variables for pre-
icting outcome and across many patient subsets (12,13).
omputed tomography angiography has not been studied in
elation to perfusion results for assessing prognosis, but
ecent data (11) suggest that a normal perfusion study
redicts a very low short-term (3 years) risk for a subse-
uent cardiac event, irrespective of CACS severity. Al-
hough a CACS cannot be directly equated to CTA
ndings, the former is a reflection of CAD extent and
everity (9). Unless other variables are derived from CTA
eyond those currently obtained with invasive angiography,
t is unlikely that CTA anatomic data will further enhance
isk stratification if the perfusion results are known. A clear
pportunity for CTA might be identification of vulnerable
laque through quantification of plaque volume and its
elative composition.
An additional challenge for CTA will be to demonstrate
ts utility in guiding patient management decisions. Stress
PI with selective coronary angiography in patients who
emonstrate ischemia is a more cost-effective strategy than
outine coronary angiography (14). The reason is that an
schemia-guided approach appropriately limits angiography
nd revascularization to the patient group at highest risk.ecent data (15,16) indicate that only 50% of patients (and
ne-third of arteries) with obstructive CAD by CTA will
ave inducible ischemia by perfusion imaging. A CTA
ssessment alone will likely result in additional interven-
ional procedures at a time when a “stenosis-only” based
reatment approach continues to be shown suboptimal and
ostly (17–19).
The future of CTA will be decided by its incremental
alue within the current imaging armamentarium. It may
ell be that selectively combining CTA with function
ssessments of ischemia will further streamline patient care
nd improve outcomes. These answers will become apparent
nly through prospective multicenter clinical trials. With
TA, are we revisiting the past with a novel noninvasive
wist, or will this technique offer something new? I believe
he latter to be true.
eprint requests and correspondence: Dr. John J. Mahmarian,
epartment of Cardiology, Methodist DeBakey Heart Center,
550 Fannin Street, SM-677, Houston, Texas 77030. E-mail:
mahmarian@tmh.tmc.edu.
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